Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Gastrointestinal Cancers Congress 2024

AiCME (supported by Bayer) - Navigating new frontiers: Real world evidence's trial in advancing later-line gastrointestinal cancer therapy

Do different sources of data matter? Comparing real-world evidence and clinical trial findings

Date

26 Jun 2024

Session

AiCME (supported by Bayer) - Navigating new frontiers: Real world evidence's trial in advancing later-line gastrointestinal cancer therapy

Topics

Tumour Site

Hepatobiliary Cancers;  Colon and Rectal Cancer

Presenters

Luís Castelo-Branco

Authors

L. Castelo-Branco1, R.D. Kim2

Author affiliations

  • 1 ESMO - European Society for Medical Oncology, Lugano/CH
  • 2 H. Lee Moffitt Cancer Center University of South Florida, Tampa/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Conclusion: Audience Q&A and closing remarks

Presenter: Luís Castelo-Branco

Session: AiCME (supported by Bayer) - Navigating new frontiers: Real world evidence's trial in advancing later-line gastrointestinal cancer therapy

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.